Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naomi Kiyota

Showing results (1-10 of 185) with videos related to

Pageof 19
Sort By:
Cancers of the Head & Neck|May 17, 2019
Optimal use of lenvatinib in the treatment of advanced thyroid cancerShunji Takahashi, Naomi Kiyota, Makoto Tahara
Japanese Journal of Clinical Oncology|November 21, 2014
Adjuvant treatment for post-operative head and neck squamous cell carcinomaNaomi Kiyota, Makoto Tahara, Masato Fujii
Japanese Journal of Clinical Oncology|March 7, 2024
Current status and future perspective of postoperative treatment for locally advanced squamous cell carcinoma of the head and neckNaomi Kiyota, Makoto Tahara, Akihiro Homma
European Thyroid Journal|March 31, 2025
Anticancer drug therapy for anaplastic thyroid cancerNaomi Kiyota, Taiji Koyama, Iwao Sugitani
Japanese Journal of Clinical Oncology|June 22, 2026
Current status and future perspectives of treatment de-escalation in localized head and neck cancerShinya Hiraoka, Takeshi Kodaira, Nobuhiro Hanai, et al.
Japanese Journal of Clinical Oncology|January 23, 2019
Controversies in relation to neck management in N0 early oral tongue cancerNobuhiro Hanai, Takahiro Asakage, Naomi Kiyota, et al.
Dermatology Reports|July 7, 2022
Severe and delayed-onset acneiform eruptions as an adverse reaction to regorafenibHaruhiko Otsuka, Takeshi Fukumoto, Naomi Kiyota, et al.
Asia-Pacific Journal of Clinical Oncology|January 31, 2022
A phase I study of LCL161, a novel oral pan-inhibitor of apoptosis protein (IAP) antagonist, in Japanese patients with advanced solid tumorsSachi Morita, Hironobu Minami, Ayako Mitsuma, et al.
Cureus|June 24, 2024
Statistical Analysis Methods and Reporting of Patient-Reported Outcomes in Randomized Controlled Trials for Cancer Conducted in Japan: A Systematic ReviewJunki Mizusawa, Gakuto Ogawa, Mitsumi Terada, et al.
International Journal of Clinical Oncology|June 10, 2021
Real-world safety and effectiveness of nivolumab for recurrent or metastatic head and neck cancer in Japan: a post-marketing surveillanceMakoto Tahara, Naomi Kiyota, Ken-Ichi Nibu, et al.
Pageof 19

Showing results (1-10 of 185) with videos related to

Sort By:
Pageof 19
Cancers of the Head & Neck|May 17, 2019
Optimal use of lenvatinib in the treatment of advanced thyroid cancerShunji Takahashi, Naomi Kiyota, Makoto Tahara
Japanese Journal of Clinical Oncology|November 21, 2014
Adjuvant treatment for post-operative head and neck squamous cell carcinomaNaomi Kiyota, Makoto Tahara, Masato Fujii
Japanese Journal of Clinical Oncology|March 7, 2024
Current status and future perspective of postoperative treatment for locally advanced squamous cell carcinoma of the head and neckNaomi Kiyota, Makoto Tahara, Akihiro Homma
European Thyroid Journal|March 31, 2025
Anticancer drug therapy for anaplastic thyroid cancerNaomi Kiyota, Taiji Koyama, Iwao Sugitani
Japanese Journal of Clinical Oncology|June 22, 2026
Current status and future perspectives of treatment de-escalation in localized head and neck cancerShinya Hiraoka, Takeshi Kodaira, Nobuhiro Hanai, et al.
Japanese Journal of Clinical Oncology|January 23, 2019
Controversies in relation to neck management in N0 early oral tongue cancerNobuhiro Hanai, Takahiro Asakage, Naomi Kiyota, et al.
Dermatology Reports|July 7, 2022
Severe and delayed-onset acneiform eruptions as an adverse reaction to regorafenibHaruhiko Otsuka, Takeshi Fukumoto, Naomi Kiyota, et al.
Asia-Pacific Journal of Clinical Oncology|January 31, 2022
A phase I study of LCL161, a novel oral pan-inhibitor of apoptosis protein (IAP) antagonist, in Japanese patients with advanced solid tumorsSachi Morita, Hironobu Minami, Ayako Mitsuma, et al.
Cureus|June 24, 2024
Statistical Analysis Methods and Reporting of Patient-Reported Outcomes in Randomized Controlled Trials for Cancer Conducted in Japan: A Systematic ReviewJunki Mizusawa, Gakuto Ogawa, Mitsumi Terada, et al.
International Journal of Clinical Oncology|June 10, 2021
Real-world safety and effectiveness of nivolumab for recurrent or metastatic head and neck cancer in Japan: a post-marketing surveillanceMakoto Tahara, Naomi Kiyota, Ken-Ichi Nibu, et al.
Pageof 19